Angela Hommel

Dresden, SN, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Determinants of Infant Participation and Non-Participation in Primary Prevention Trials.

Determinants of Infant Participation and Non-Participation in Primary Prevention Trials.

Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

Published: July 01, 2026

Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trial.

Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trial.

Journal: Lancet (London, England)

Published: June 30, 2025

Blood methylome signatures in children exposed to maternal type 1 diabetes are linked to protection against islet autoimmunity.

Blood methylome signatures in children exposed to maternal type 1 diabetes are linked to protection against islet autoimmunity.

Journal: Nature metabolism

Published: March 28, 2025

Infection episodes and islet autoantibodies in children at increased risk for type 1 diabetes before and during the COVID-19 pandemic.

Infection episodes and islet autoantibodies in children at increased risk for type 1 diabetes before and during the COVID-19 pandemic.

Journal: Infection

Published: March 06, 2024

Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes.

Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes.

Journal: Diabetologia

Published: August 14, 2023

Vitamin D insufficiency in infants with increased risk of developing type 1 diabetes: a secondary analysis of the POInT Study.

Vitamin D insufficiency in infants with increased risk of developing type 1 diabetes: a secondary analysis of the POInT Study.

Journal: BMJ paediatrics open

Published: August 02, 2023

Presymptomatic type 1 diabetes and disease severity at onset.

Presymptomatic type 1 diabetes and disease severity at onset.

Journal: Diabetologia

Published: July 21, 2023

The emotional well-being of parents with children at genetic risk for type 1 diabetes before and during participation in the POInT-study.

The emotional well-being of parents with children at genetic risk for type 1 diabetes before and during participation in the POInT-study.

Journal: Pediatric diabetes

Published: August 11, 2022

Elevations in blood glucose before and after the appearance of islet autoantibodies in children.

Elevations in blood glucose before and after the appearance of islet autoantibodies in children.

Journal: The Journal of clinical investigation

Published: May 24, 2022

The Willingness to Participate in Pediatric Type 1 Diabetes Studies.

The Willingness to Participate in Pediatric Type 1 Diabetes Studies.

Journal: Deutsches Arzteblatt international

Published: November 04, 2021

Transient Depletion of Foxp3+ Regulatory T Cells Selectively Promotes Aggressive β Cell Autoimmunity in Genetically Susceptible DEREG Mice.

Transient Depletion of Foxp3+ Regulatory T Cells Selectively Promotes Aggressive β Cell Autoimmunity in Genetically Susceptible DEREG Mice.

Journal: Frontiers in immunology

Published: June 03, 2021

Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials-GPPAD-02 study design and first results.

Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials-GPPAD-02 study design and first results.

Journal: Pediatric diabetes

Published: February 11, 2019

Showing 1-12 of 18

Last Updated: 09/26/2026